AI assistant
NIOCORP DEVELOPMENTS LTD — Director's Dealing 2022
Nov 29, 2022
32677_dirs_2022-11-29_72424d3c-ca4e-4a07-9989-7d9c2a65d66b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NIOCORP DEVELOPMENTS LTD (NIOBF)
CIK: 0001512228
Period of Report: 2022-11-28
Reporting Person: Guerrero-Mahon Nilsa (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-28 | Common Shares | M | 500000 | $0.3513 | Acquired | 500000 | Direct |
| 2022-11-28 | Common Shares | F | 200855 | $0.8746 | Disposed | 299145 | Direct |
| 2022-11-28 | Common Shares | M | 300000 | $0.4037 | Acquired | 599145 | Direct |
| 2022-11-28 | Common Shares | F | 138462 | $0.8746 | Disposed | 460682 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-28 | Director Stock Option (right to buy) | $0.3513 | M | 500000 | Disposed | 2022-11-30 | Common Shares (500000) | Direct |
| 2022-11-28 | Director Stock Option (right to buy) | $0.4037 | M | 300000 | Disposed | 2023-11-15 | Common Shares (300000) | Direct |
Footnotes
F1: Option exercise price reflected was converted from Canadian exercise price of C$0.47 using an exchange rate of C$1.3377 = US$1.00 as reported by the Bank of Canada on November 25, 2022.
F2: Sale price of common shares withheld in satisfaction of option exercise price is based on the closing price of the common shares on the Toronto Stock Exchange on November 25, 2022 of C$1.17, which was converted using an exchange rate of C$1.3377 = US$1.00 as reported by the Bank of Canada on November 25, 2022.
F3: Option exercise price reflected was converted from Canadian exercise price of C$0.54 using an exchange rate of C$1.3377 = US$1.00 as reported by the Bank of Canada on November 25, 2022.
F4: The option, representing a right to purchase a total of 500,000 Common Shares, became exercisable on the issuance date of November 9, 2017.
F5: The option, representing a right to purchase a total of 300,000 Common Shares, became exercisable in installments as follows: 50% on May 15, 2019; 25% on November 15, 2019; and 25% on May 15, 2020.